5656 related articles for article (PubMed ID: 3447537)
1. Antineoplastic activity of new linear hydrazine derivatives.
Fiszer-Maliszewska L; Peczyńska-Czoch W; Wieczorek J; Mordarski M; Balicki R; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1987; 35(2):225-35. PubMed ID: 3447537
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
Karaivanova MH; Zakhariev SG; Golovinsky EV
Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic activity of azacarbazoles. II. Effect of alpha-carboline and its derivatives on transplantable animal neoplasms.
Fiszer-Maliszewska L; Mordarski M
Arch Immunol Ther Exp (Warsz); 1987; 35(2):221-4. PubMed ID: 3447536
[TBL] [Abstract][Full Text] [Related]
4. Isothiazolopyrimidines--new group of anticancer agents. I.
Machoń Z; Wieczorek J; Mordarski M
Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
[TBL] [Abstract][Full Text] [Related]
5. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180].
Jugstand W; Gutsche W; Wiangke H
Arzneimittelforschung; 1966 May; 16(5):634-7. PubMed ID: 6014431
[No Abstract] [Full Text] [Related]
6. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
Mazerska Z; Lukowicz J; Konopa J
Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
[TBL] [Abstract][Full Text] [Related]
7. Cancerostatica. II. Synthesis and preliminary cytostatic screening of some alpha-carboline derivatives.
Nantka-Namirski P; Kaczmarek L
Pol J Pharmacol Pharm; 1978; 30(4):569-72. PubMed ID: 740558
[TBL] [Abstract][Full Text] [Related]
8. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
Finch RA; Shyam K; Penketh PG; Sartorelli AC
Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of 2-chloroethyl (methylsulfonyl)methanesulfonate (clomesone, NSC 33847) against selected tumor systems in mice.
Dykes DJ; Waud WR; Harrison SD; Laster WR; Griswold DP; Shealy YF; Montgomery JA
Cancer Res; 1989 Mar; 49(5):1182-6. PubMed ID: 2537144
[TBL] [Abstract][Full Text] [Related]
10. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
11. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
Mihich E; Gelzer J
Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
[No Abstract] [Full Text] [Related]
12. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives.
Nantka-Namirski P; Kaczmarek L
Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557
[TBL] [Abstract][Full Text] [Related]
13. Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
Mordarski M; Chylińska B; Urbański T
Arch Immunol Ther Exp (Warsz); 1970; 18(6):679-99. PubMed ID: 5493086
[No Abstract] [Full Text] [Related]
14. Antitumor activities of newly synthesized 5-carbamoyl-1 H-imidazol-4yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4yl piperonylate.
Yoshida N; Kiyohara T; Fukui M; Atsumi T; Ogino S; Inaba M; Tsukagoshi S; Sakurai Y
Cancer Res; 1980 Oct; 40(10):3810-4. PubMed ID: 7438064
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
Mihich E; Nichol CA
Cancer Res; 1965 Jul; 25(6):794-801. PubMed ID: 5214034
[No Abstract] [Full Text] [Related]
16. [Antitumor activity of the components of a carminomycin complex].
Shorin VA; Bazhanov VS; Averbukh LA
Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
[TBL] [Abstract][Full Text] [Related]
17. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
[No Abstract] [Full Text] [Related]
18. Cancerostatics. Part V. Synthesis of some acyl hydrazine derivatives.
Balicki R; Nantka-Namirski P
Acta Pol Pharm; 1988; 45(1):1-7. PubMed ID: 3138893
[No Abstract] [Full Text] [Related]
19. [Antitumor activity of prospidin].
Sorkina IuA; Chernov VA; Grushina AA; Khramchenkova SP
Vopr Onkol; 1970; 16(7):83-6. PubMed ID: 5274101
[No Abstract] [Full Text] [Related]
20. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.
Hickman JA; Stevens MF; Gibson NW; Langdon SP; Fizames C; Lavelle F; Atassi G; Lunt E; Tilson RM
Cancer Res; 1985 Jul; 45(7):3008-13. PubMed ID: 4005840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
